Former Brevan Howard Asset Management Traders to Launch $100M Natural Resources Fund Next Year

Tim Whyte, Carl Linderum and Ben Belldegrun are starting a $100 million natural resources hedge fund. It is expected to launch next year.

Alan Howard

Tim Whyte, Carl Linderum and Ben Belldegrun’s New Fund

Tim Whyte, Carl Linderum and Ben Belldegrun are starting their own natural resources fund after spending two years as senior traders at Brevan Howard Asset Management. According to FINAlternatives, the trio have already raised the capital for their fund. Citing a “person familiar with the situation,” the online news source writes, “Tim Whyte, Carl Linderum and Ben Belldegrun have yet to name their new firm, reports Financial News… Whyte will be the new outfit’s CIO, with Linderum and Belldegrun as senior partners on the investment team. FN says the fund will focus on global commodities and equities.”

Tim Whyte, Carl Linderum and Ben Belldegrun Bring Common Experience

The trio are very well versed in managing Natural resources hedge funds. Tim Whyte, Carl Linderum and Ben Belldegrun left Brevan Howard Asset Management in 2010. Before joining the firm in 2008, the three men ran the natural resources hedge fund at Sofaer Capital. Whyte,  who one of London’s top hedge fund managers, managed the Natural Resources fund there. Whyte left Sofaer at the end of June 2008 after accepting a position from Brevan Howard. The fund lost 17.4 percent in July 2008 reports HedgeWeb. Prior to those losses, Whyte’s fund gained 57 percent in 2007 and 79 percent in 2006. Whyte also has experience as the director of the Far East Energy Corp, according to the Oil&GasFinancialJournal.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!